{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-mitochondrial-myopathy-with-exercise-intolerance","columns":[{"gene":"","key":"population-461ddd300411d8213016","label":"Myopathy, isolated mitochondrial, autosomal dominant","mondoId":"MONDO:0014532","onsetQualifier":null,"originColumnKey":"MONDO:0014532/OMIM:616209","originalViews":[{"key":"MONDO:0014532/OMIM:616209","label":"Myopathy, isolated mitochondrial, autosomal dominant","scopeLabel":"OMIM:616209","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["02a9314f5ea9a179d5c8a3ae96e46b52364147a86cbf40f0fc1315a9555abe47","32d98b78fad8f71df8298cc7a95dc127ef6871eac3a1dab4c116a61e6e065a26","37013287d07301ed9bf2a9bba8352e8cb60c8eff3ecca62129fe9e793785db68","4e66abb4981c0621f5aa853982ac64751191a6c4fbef53b9037b8ac170d3bd27","69c6406e3d50f12ff7761985ec0ae07de3bbd02d9168dd3cc8305de7a604be95","7c41ae45c10990748d7ec31b58c8f3b27526133b2b8ce8e7c5f8811ec3d07d77","7f6f9973d3ce0a22128d0993055515ecedab03dff5a446af89e6026315a44432","92033d7aa4b3a1a747213400514cacacf169163deb12a42f441e6e004869b2f2","cc245420ed7548b125a2fb95fe7b778013cd2ef57910155c6dc9acb2473dbf27","eb99a3b90ee8753c945e846c43a11e7111d8f8cb19dd25b29e3f8265d16ac8eb","f9a8c57d949e6484a7107f3fd55703e4fe65b59c612fa7f0fa434d1991bd22c1"],"recordQualifiers":{},"scopeLabel":"OMIM:616209","sourceIds":["OMIM:616209"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-80b8b72ed1e75ab5e2ef","label":"Autosomal dominant mitochondrial myopathy with exercise intolerance","mondoId":"MONDO:0014532","onsetQualifier":null,"originColumnKey":"MONDO:0014532/ORPHA:457050","originalViews":[{"key":"MONDO:0014532/ORPHA:457050","label":"Autosomal dominant mitochondrial myopathy with exercise intolerance","scopeLabel":"ORPHA:457050","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0391ac82c4573997ec5a35d9a0853e0495f77d7d4eef0acacc55ccf3415c8eb7","0f5431445b5a33bb4032f15bcc86ea92ccde0d4db151d9d8d939f7ba722c2144","399c92e0c5e60ea71bc8426315ff1f44467e18052cecf2d723b5d446882ddbf8","814e6a399c083dc13b030e17db27729e6ab819c384eef17f5cf575d20dd2f28b","86fda89d7c66949aaec300156cfb94d16c608e5d11fc9d201c41092c1bf981f8","aee6df2126422fb599ba8981fc9d89899f13881fc2c6d4e563e6c2ededd39c57","c85594a7a5aeb8e2310008dde07fac22bc201aa03e5358662e82e26f6706d38a","d6bd3268a2255107e3fdbb540695f63044a350e5d3788ee7030f0b7b14a0b269","e10f169c7bc1e4728dbecd0f2c38af7a1730633177f3838d630ae2ba458d8e1d","eb6ad5bb0168e1b9422b9e6314ff2dd38ed6d37217600458156f6a164257a50a","ef7bdbc044e91428a10edc90e758d70272b760cc163fbf6158947fde79ccbada","f8ad363c7087a844ce34c826a6dc32e47e7a2c66b4b781fefb103837de0affbf","ff281d7c2fa6ee081ee83a18a2bf625e4b2db8cbff0583b59355682a5685dc01"],"recordQualifiers":{},"scopeLabel":"ORPHA:457050","sourceIds":["ORPHA:457050"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-461ddd300411d8213016","population-80b8b72ed1e75ab5e2ef"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0008314","HP:0011924","HP:0008347","HP:0009053","HP:0003236","HP:0003546","HP:0010628"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":3,"orphanet":13,"published":8}},"features":[{"hpoId":"HP:0008314","label":"Decreased activity of mitochondrial complex II","primary":true},{"hpoId":"HP:0011924","label":"Decreased activity of mitochondrial complex III","primary":true},{"hpoId":"HP:0008347","label":"Decreased activity of mitochondrial complex IV","primary":true},{"hpoId":"HP:0009053","label":"Distal lower limb muscle weakness","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0003546","label":"Exercise intolerance","primary":true},{"hpoId":"HP:0010628","label":"Facial palsy","primary":true},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0012240","label":"Increased intramyocellular lipid droplets","primary":false},{"hpoId":"HP:0040014","label":"Increased mitochondrial number","primary":false},{"hpoId":"HP:0008180","label":"Mildly elevated creatine kinase","primary":false},{"hpoId":"HP:0003722","label":"Neck flexor weakness","primary":false},{"hpoId":"HP:0008994","label":"Proximal lower limb muscle weakness","primary":false},{"hpoId":"HP:0008997","label":"Proximal upper limb muscle weakness","primary":false},{"hpoId":"HP:0003200","label":"Ragged-red muscle fibers","primary":false},{"hpoId":"HP:0002091","label":"Restrictive ventilatory defect","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0030319","label":"Weakness of facial musculature","primary":false}],"ledeHtml":"A rare mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies characterized by onset of slowly progressive proximal lower limb weakness and exercise intolerance in the first decade of life, followed by weakness of neck flexor, shoulder, and distal leg muscles. Facial muscles become involved still later in the disease course. Additional manifestations are restrictive pulmonary function and short stature. Laboratory studies reveal lactic acidemia and increased serum creatine kinase.","mondoId":"MONDO:0014532","node":{"canonicalSlug":"autosomal-dominant-mitochondrial-myopathy-with-exercise-intolerance","comparisons":[{"documentSha256":"35e0b0d8669dc30f99b8153d655dfb329cfd2786a1356908b5ec6563c0a2a6bd","key":"legacy-autosomal-dominant-mitochondrial-myopathy-with-exercise-intolerance","kind":"legacy","label":"autosomal dominant mitochondrial myopathy with exercise intolerance","memberIds":["MONDO:0014532"],"mondoId":"MONDO:0014532","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autosomal-dominant-mitochondrial-myopathy-with-exercise-intolerance.35e0b0d8669dc30f99b8153d655dfb329cfd2786a1356908b5ec6563c0a2a6bd.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","originalSourceId":"ORPHA:457050","paragraphs":["A rare mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies characterized by onset of slowly progressive proximal lower limb weakness and exercise intolerance in the first decade of life, followed by weakness of neck flexor, shoulder, and distal leg muscles. Facial muscles become involved still later in the disease course. Additional manifestations are restrictive pulmonary function and short stature. Laboratory studies reveal lactic acidemia and increased serum creatine kinase."],"rawAttribution":"ORPHA:457050","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:54Z","upstream":"ORPHA:457050","url":"https://rarediseases.info.nih.gov/diseases/17794"},"ownColumnKeys":["population-461ddd300411d8213016","population-80b8b72ed1e75ab5e2ef"],"publication":"published","relationships":[{"kind":"parent","label":"inborn mitochondrial myopathy","mondoId":"MONDO:0009637","slug":null},{"kind":"parent","label":"mitochondrial oxidative phosphorylation disorder","mondoId":"MONDO:0016387","slug":"mitochondrial-oxidative-phosphorylation-disorder"},{"kind":"parent","label":"metabolic myopathy","mondoId":"MONDO:0020123","slug":"metabolic-myopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"02a9314f5ea9a179d5c8a3ae96e46b52364147a86cbf40f0fc1315a9555abe47","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0391ac82c4573997ec5a35d9a0853e0495f77d7d4eef0acacc55ccf3415c8eb7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003200","is_excluded":false,"label":"Ragged-red muscle fibers","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0f5431445b5a33bb4032f15bcc86ea92ccde0d4db151d9d8d939f7ba722c2144","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040014","is_excluded":false,"label":"Increased mitochondrial number","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"32d98b78fad8f71df8298cc7a95dc127ef6871eac3a1dab4c116a61e6e065a26","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0008314","is_excluded":false,"label":"Decreased activity of mitochondrial complex II","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"37013287d07301ed9bf2a9bba8352e8cb60c8eff3ecca62129fe9e793785db68","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0008994","is_excluded":false,"label":"Proximal lower limb muscle weakness","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"399c92e0c5e60ea71bc8426315ff1f44467e18052cecf2d723b5d446882ddbf8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012240","is_excluded":false,"label":"Increased intramyocellular lipid droplets","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4e66abb4981c0621f5aa853982ac64751191a6c4fbef53b9037b8ac170d3bd27","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010628","is_excluded":false,"label":"Facial palsy","onset_id":null,"reference":"OMIM:616209","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"69c6406e3d50f12ff7761985ec0ae07de3bbd02d9168dd3cc8305de7a604be95","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"OMIM:616209","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7c41ae45c10990748d7ec31b58c8f3b27526133b2b8ce8e7c5f8811ec3d07d77","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7f6f9973d3ce0a22128d0993055515ecedab03dff5a446af89e6026315a44432","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"OMIM:616209","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"814e6a399c083dc13b030e17db27729e6ab819c384eef17f5cf575d20dd2f28b","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86fda89d7c66949aaec300156cfb94d16c608e5d11fc9d201c41092c1bf981f8","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002091","is_excluded":false,"label":"Restrictive ventilatory defect","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"92033d7aa4b3a1a747213400514cacacf169163deb12a42f441e6e004869b2f2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003200","is_excluded":false,"label":"Ragged-red muscle fibers","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"aee6df2126422fb599ba8981fc9d89899f13881fc2c6d4e563e6c2ededd39c57","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008994","is_excluded":false,"label":"Proximal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c85594a7a5aeb8e2310008dde07fac22bc201aa03e5358662e82e26f6706d38a","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"cc245420ed7548b125a2fb95fe7b778013cd2ef57910155c6dc9acb2473dbf27","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003722","is_excluded":false,"label":"Neck flexor weakness","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d6bd3268a2255107e3fdbb540695f63044a350e5d3788ee7030f0b7b14a0b269","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009053","is_excluded":false,"label":"Distal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e10f169c7bc1e4728dbecd0f2c38af7a1730633177f3838d630ae2ba458d8e1d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb6ad5bb0168e1b9422b9e6314ff2dd38ed6d37217600458156f6a164257a50a","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030319","is_excluded":false,"label":"Weakness of facial musculature","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"eb99a3b90ee8753c945e846c43a11e7111d8f8cb19dd25b29e3f8265d16ac8eb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0008347","is_excluded":false,"label":"Decreased activity of mitochondrial complex IV","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ef7bdbc044e91428a10edc90e758d70272b760cc163fbf6158947fde79ccbada","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008180","is_excluded":false,"label":"Mildly elevated creatine kinase","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f8ad363c7087a844ce34c826a6dc32e47e7a2c66b4b781fefb103837de0affbf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003722","is_excluded":false,"label":"Neck flexor weakness","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f9a8c57d949e6484a7107f3fd55703e4fe65b59c612fa7f0fa434d1991bd22c1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616209","disease_name":"Myopathy, isolated mitochondrial, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0011924","is_excluded":false,"label":"Decreased activity of mitochondrial complex III","onset_id":null,"reference":"PMID:25193783","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ff281d7c2fa6ee081ee83a18a2bf625e4b2db8cbff0583b59355682a5685dc01","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:457050","disease_name":"Autosomal dominant mitochondrial myopathy with exercise intolerance","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008997","is_excluded":false,"label":"Proximal upper limb muscle weakness","onset_id":null,"reference":"ORPHA:457050","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17794\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:457050</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies characterized by onset of slowly progressive proximal lower limb weakness and exercise intolerance in the first decade of life, followed by weakness of neck flexor, shoulder, and distal leg muscles. Facial muscles become involved still later in the disease course. Additional manifestations are restrictive pulmonary function and short stature. Laboratory studies reveal lactic acidemia and increased serum creatine kinase.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17794\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-dominant-mitochondrial-myopathy-with-exercise-intolerance","sourceDocuments":[{"name":"GARD: Autosomal dominant mitochondrial myopathy with exercise intolerance","reviewed":null,"source_release":"2026-10-21T17:02:54Z","url":"https://rarediseases.info.nih.gov/diseases/17794"}],"sourceNote":"","synonyms":["IMMD","myopathy, isolated mitochondrial, autosomal dominant"],"takeawayHtml":"","title":"autosomal dominant mitochondrial myopathy with exercise intolerance"},"schemaVersion":1}
